THU170 Clinical And Immunological Response To Somatrogon In Two Siblings With A Homozygous Whole Gene Deletion Of The Growth Hormone 1 Gene

por Gupta, Rahul, Khadgawat, Rajesh, Rosenfeld, Ron G, Dattani, Mehul T, Dyer, Lisa, Friedman, Bethany, Korth-Bradley, Joan, Nijher, Monica, Roland, Carl L, Taylor, Carrie T, Cara, Jose F, Hsiao, Jane, Wajnrajch, Michael P
Publicado 2023

OR21-04 Long-term Efficacy And Safety Of Once-weekly Somatrogon In Pediatric Subjects With Growth Hormone Deficiency: Results From Up To 8 Years Of Somatrogon Treatment

por Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievskiy, Oleg A, Mauras, Nelly, Valluri, Srinivas R, Pastrak, Aleksandra, Rosenfeld, Ron G, Taylor, Carrie T, Nijher, Monica, Roland, Carl, Wang, Ronnie, Wajnrajch, Michael P, Cara, Jose F
Publicado 2023

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

por Deal, Cheri L, Steelman, Joel, Vlachopapadopoulou, Elpis, Stawerska, Renata, Silverman, Lawrence A, Phillip, Moshe, Kim, Ho-Seong, Ko, CheolWoo, Malievskiy, Oleg, Cara, Jose F, Roland, Carl L, Taylor, Carrie Turich, Valluri, Srinivas Rao, Wajnrajch, Michael P, Pastrak, Aleksandra, Miller, Bradley S
Publicado 2022